Back to Search
Start Over
Discovery and development of potent and selective inhibitors of histone methyltransferase g9a.
- Source :
-
ACS medicinal chemistry letters [ACS Med Chem Lett] 2014 Jan 02; Vol. 5 (2), pp. 205-9. Date of Electronic Publication: 2014 Jan 02 (Print Publication: 2014). - Publication Year :
- 2014
-
Abstract
- G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.
Details
- Language :
- English
- ISSN :
- 1948-5875
- Volume :
- 5
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- ACS medicinal chemistry letters
- Publication Type :
- Academic Journal
- Accession number :
- 24900801
- Full Text :
- https://doi.org/10.1021/ml400496h